- Home
- RPRX vs J Comparison
RPRX vs J Comparison
Compare RPRX & J Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- J
- Stock Information
- Founded
- RPRX 1996
- J 1947
- Country
- RPRX United States
- J United States
- Employees
- RPRX N/A
- J N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- J Military/Government/Technical
- Sector
- RPRX Health Care
- J Industrials
- Exchange
- RPRX Nasdaq
- J Nasdaq
- Market Cap
- RPRX 13.9B
- J 15.5B
- IPO Year
- RPRX 2020
- J N/A
- Fundamental
- Price
- RPRX $33.58
- J $127.43
- Analyst Decision
- RPRX Strong Buy
- J Buy
- Analyst Count
- RPRX 3
- J 8
- Target Price
- RPRX $47.33
- J $150.86
- AVG Volume (30 Days)
- RPRX 5.5M
- J 706.5K
- Earning Date
- RPRX 05-08-2025
- J 08-05-2025
- Dividend Yield
- RPRX 2.62%
- J 0.92%
- EPS Growth
- RPRX 37.60
- J N/A
- EPS
- RPRX 2.45
- J 3.66
- Revenue
- RPRX $2,263,845,000.00
- J $11,686,906,000.00
- Revenue This Year
- RPRX $29.35
- J N/A
- Revenue Next Year
- RPRX $7.58
- J $6.06
- P/E Ratio
- RPRX $13.70
- J $34.85
- Revenue Growth
- RPRX 1.13
- J 35.39
- 52 Week Low
- RPRX $24.05
- J $105.18
- 52 Week High
- RPRX $34.32
- J $149.05
- Technical
- Relative Strength Index (RSI)
- RPRX 56.69
- J 56.29
- Support Level
- RPRX $33.37
- J $124.63
- Resistance Level
- RPRX $33.97
- J $128.76
- Average True Range (ATR)
- RPRX 0.53
- J 1.99
- MACD
- RPRX 0.05
- J -0.14
- Stochastic Oscillator
- RPRX 76.06
- J 67.95
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About J Jacobs Solutions Inc.
Jacobs Solutions is a global provider of engineering, design, procurement, construction, and maintenance services as well as cyber engineering and security solutions. The firm serves industrial, commercial, and government clients in a wide variety of sectors, including water, transportation, healthcare, technology, and chemicals. Jacobs Solutions employs approximately 60,000 workers. The company generated $11.5 billion in revenue in fiscal 2024.